Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia

Harm Reduction Journal

Volumn 6, Issue , 2009, Pages

  Vorobjov, Sigrid ^a,b   Uusküla, Anneli ^b,c   Abel Ollo, Katri ^a   Talu, Ave ^a   Rüütel, Kristi ^a,c   Des Jarlais, Don C ^d  

^a NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

^c UNIVERSITY OF TARTU   (Estonia)

^d BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; ESTONIA; FEMALE; HARM REDUCTION; HEALTH BEHAVIOR; HEALTH CARE NEED; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INJECTION; INTRAVENOUS DRUG ABUSE; MALE; PHARMACY; PREVALENCE; RISK FACTOR; SCHOOL CHILD; SELF REPORT; SEXUALITY; SYRINGE;

EID: 62649145646     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-6-3     Document Type: Article

References (43)

1. The Centralized Information System for Infectious Diseases http://data.euro.who.int/cisid/
2. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) http://www.unaids.org/en/KnowledgeCentre/HIVData/ EpiUpdate/EpiUpdArchive/2006/Default.asp
3. Des Jarlais DC Marmor M Friedmann P Titus S Aviles E Deren S Torian L Glebatis D Murrill C Monterroso E Friedman SR: HIV incidence among injection drug users in New York City, 1992-1997: Evidence for a declining epidemic. Am J of Public Health 2000, 90:352-359. 10.2105/ AJPH.90.3.352
4. Hagan H Des Jarlais DC Friedman SR Purchase D Alter MJ: Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J of Public Health 1995, 85:1531-1537. 10.2105/AJPH.85.11.1531
5. Des Jarlais D Marmor M Paone D Titus S Shi Q Perlis T Jose B Friedman SR: HIV incidence among injecting drug users in New York City syringe- exchange programmes. Lancet 1996, 348:987-991. 10.1016/ S0140-6736(96)02536-6 8855855
6. Sheridan J Strang J Barber N Glanz A: Role of community pharmacies in relation to HIV prevention and drug misuse: Findings from the 1995 national survey in England and Wales. BMJ 1996, 313:272-274. 2351660 8704541
7. Strang J Sheridan J Barber N: Prescribing injectable and oral methadone to opiate addicts: Results from the 1995 national postal survey of community pharmacies in England and Wales. BMJ 1996, 313:270-272. 2351715 8704540
8. Lurie P Jones TS Foley J: A sterile syringe for every drug user injection: How many injections take place annually, and how might pharmacists contribute to syringe distribution?. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18(Suppl 1):S45-S51. 9663623
9. Matheson C Bond CM Pitcairn J: Community pharmacy services for drug misusers in Scotland: What difference does 5 years make?. Addiction 2002, 97:1405-1411. 10.1046/j.1360-0443.2002.00241.x 12410781
10. Thein HH Denoe M van Beek I Dore G MacDonald M: Injecting behaviour of injecting drug users at needle and syringe programmes and pharmacies in Australia. Int J Drug Policy 2003, 14:425-430. 10.1016/ j.drugpo.2003.06.001
11. Estonian Drug Monitoring Centre National Focal Point National Report on Drug Situation in Estonia 2001. Tallinn 2002
12. National Institute for Health Development: Global Fund Report 2006 http://www2.tai.ee/teated/GF/ Global_Fundi_Programmi2006kalendriaasta_aruanne.pdf
13. Uusküla A Rajaleid K Talu A Abel K Rüütel K Hay G: Estimating injection drug use prevalence using state wide administrative data sources: Estonia, 2004. Addict Res Theory 2007, 15:411-424. 10.1080/ 16066350701417533
14. Uusküla A McNutt LA Dehovitz J Fischer K Heimer R: High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia. Int J of STD AIDS 2007, 18:41-46. 10.1258/095646207779949907
15. Wilson TE Sharma A Zilmer K Kalikova N Uusküla A: The HIV prevention needs of injection drug users in Estonia. Int J of STD AIDS 2007, 18:389-391. 10.1258/095646207781024900
16. Uusküla A Kals M Rajaleid K Abel K Talu A Rüütel K Platt L Rhodes T Dehovitz J Des Jarlais D: High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs. J Public Health (Oxf) 2008, 30:119-125. 10.1093/pubmed/fdn014 18308743
17. Heckathorn DD: Respondent driven sampling: A new approach to the study of hidden population. Soc Probl 1997, 44:174-199. 10.1525/ sp.1997.44.2.03x0221m
18. Heckathorn DD Semaan S Broadhead RS Hughes JJ: Extensions of Respondent-Driven Sampling: A New Approach to the Study of Injection Drug Users Aged 18-25. AIDS Behav 2002, 6:55-67. 10.1023/A:1014528612685
19. Heckathorn DD: RespondentDdriven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl 2002, 49:11-34. 10.1525/sp.2002.49.1.11
20. Salganik MJ Heckathorn DD: Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Methodol 2004, 34:193-239. 10.1111/j.0081-1750.2004.00152.x
21. Des Jarlais DC Perlis TE Stimson GV Poznyak V: WHO Phase II Drug Injection Collaborative Study Group Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: Case study from the WHO Drug Injection Study Phase II. BMC Public Health 2006, 6:54. 1468407 16512922 10.1186/1471-2458-6-54
22. Weber B: Multicenter evaluation of the new automated Enzymun-Test Anti-HIV 1 + 2 + subtyp O. J Clin Microbiol 1998, 36:580-584. 104583 9466782
23. Thorstensson R Andersson S Lindbäck S Dias F Mhalu F Gaines H Biberfeld G: Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel. J Clin Microbiol 1998, 70:139-151. 9562408
24. Victora CG Huttly SR Fuchs SC Olinto MT: The role of conceptual frameworks in epidemiological analysis: A hierarchical approach. Int J Epidemiol 1997, 26:224-227. 10.1093/ije/26.1.224 9126524
25. StataCorp: Stata Statistical Software: Relase 9 College Station, TX: Stata Corp LP 2005
26. Uusküla A Abel K Rajaleid K Rüütel K Talu A Fischer K Boborova N: HIV and risk behaviour among injecting drug users in two cities (Tallinn, Kohtla-Järve) in Estonia. http://www.tai.ee/failid/ IDU_risk_behaviour_and_HIV_prevalence_study_2005.pdf.
27. Deren S Fuller C Pouget E Blaney S Tortu S Kang S McMahon JM Andia J Des Jarlais D Johnson S Rosenblum A Vlahov D: Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA. Int J Drug Policy 2003, 14:373-379. 10.1016/S0955-3959(03)00137-3
28. Fuller CM Galea S Blaney S Ompad DC Deren S Des Jarlais D Vlahov D: Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethn Dis 2004, 14:589-596. 15724781
29. Cao W Treloar C: Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales. Drug Alcohol Rev 2006, 25:439-444. 10.1080/09595230600891282 16939939
30. Moatti JP Vlahov D Feroni I Perrin V Obadia Y: Multiple access to sterile syringes for injection drug users: Vending machines, needle exchange programs and legal pharmacy sales in Marseille, France. Eur Addict Res 2001, 7:40-45. 10.1159/000050713 11316925
31. Des Jarlais DC Friedman SR Perlis T Chapman TF Sotheran JL Paone D Monterroso E Neaigus A: Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. J Acquir Immune Defic Syndr Hum Retrovirol 1999, 20:67-72. 9928732
32. Chitwood DD Comerford M Kitner KR Palacios W Sanchez J: A comparison of HIV risk behaviors between new and long-term injection drug users. Subst Alcohol Actions Misuse 2000, 36:91-111. 10.1081/JA-100000230
33. Hacker MA Friedman SR Telles PR Teixeira SL Bongertz V Morgado MG Bastos FI: The role of "long-term" and "new" injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil. Subst Use Misuse 2005, 40:99-123. 10.1081/JA-200030511 15702651
34. Judd A Hickman M Jones S McDonald T Parry JV Stimson GV Hall AJ: Incidence of hepatitis C virus and HIV among new injecting drug users in London: Prospective cohort study. BMJ 2005, 330:24-25. 539846 15533854 10.1136/bmj.38286.841227.7C
35. Maher L Li J Jalaludin B Chant KG Kaldor JM: High hepatitis C incidence in new injecting drug users: A policy failure?. Aust N Z J Public Health 2007, 31:30-35. 10.1111/j.1753-6405.2007.00007.x 17333606
36. Taussig J Junge B Burris S Jones TS Sterk CE: Individual and structural influences shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia. J Am Pharm Assoc 2002, 42:40-45. 10.1331/ 1086-5802.42.0.S40.Taussig
37. Lewis BA Koester SK Bush TW: Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. J Am Pharm Assoc 2002, 42:46-51. 10.1331/1086-5802.42.0.S46.Lewis
38. Sheridan J Strang J Taylor C Barber N: HIV prevention and drug treatment services for drug misusers: A national study of community pharmacists' attitudes and their involvement in service specific training. Addiction 1997, 92:1737-1748. 10.1111/j.1360-0443.1997.tb02894.x 9581006
39. Matheson C Bond CM Mollison J: Attitudinal factors associated with community pharmacists' involvement in services for drug misusers. Addiction 1999, 94:1349-1359. 10.1046/j.1360-0443.1999.94913497.x 10615720
40. Coffin PO Linas BP Factor SH Vlahov D: New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. J Urban Health 2000, 77:781-793. 10.1007/BF02344038 11194317
41. Rich JD Martin EG Macalino GE Paul RV McNamara S Taylor LE: Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island. J Am Pharm Assoc (Wash) 2002, 42:S58-61. 10.1331/ 1086-5802.42.0.S58.Rich 12489617
42. Aceijas C Hickman M Donoghoe MC Burrows D Stuikyte R: Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia. Addiction 2007, 102:1244-1250. 10.1111/ j.1360-0443.2007.01848.x 17565564
43. Sarang A Rhodes T Platt L: Access to syringes in three Russian cities: implications for syringe distribution and coverage. Int J Drug Policy 2008, 19(Suppl 1):25-36. 10.1016/j.drugpo.2007.11.008